布地奈德联合刺五加治疗神经性哮喘临床观察  

Clinical observation on treatment of neuroasthma with budesonide combined with acanthopanax senticosus (刺五加)

作　　者：江兴堂[1] 杜艳萍[1] 江毅芳[1] 

机构地区：[1]厦门大学医学院第一临床学院

出　　处：《中国中西医结合急救杂志》2003年第2期108-110,共3页Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care

摘　　要：目的 :观察布地奈德吸入联合刺五加注射液静脉滴注治疗神经性哮喘的疗效并探讨其作用机制。方法 :6 8例神经性哮喘患者随机分为 3组 ,分别用布地奈德气雾剂吸入联合刺五加注射液静脉滴注 (联合治疗组 )、单纯布地奈德气雾剂吸入 (布地奈德组 )和单纯刺五加注射液静脉滴注 (刺五加组 ) ,治疗 2周。观察治疗前后 3组患者的临床症状和肺功能变化。结果 :3组患者临床症状和肺功能均较治疗前显著改善 ( P<0 .0 5或P<0 .0 1) ,以联合治疗组改善最为明显 ( P<0 .0 5或 P<0 .0 1)。结论 :布地奈德气雾剂吸入联合刺五加注射液静脉滴注治疗神经性哮喘安全有效。Objective:To observe the efficacy of budesonide inhalation combined with acanthopanax senticosus injection(刺五加注射液) infused intravenously taken in treating patients of neuroasthma,and to investigate its mechanism.Methods:Sixtyeight patients of neuroasthma were divided into three groups randomly,treated with budesonide inhalation combined with acanthopanax senticosus injection infused intravenously(combined therapy group),budesonide inhalation alone(budesonide group) and acanthopanax senticosus injection infused intravenously alone(acanthopanax senticosus group) respectively for 2 weeks.The changes of clinical symptoms and pulmonary function before and after treatment were observed.Results:The clinical symptoms and pulmonary function were improved in all the three groups after treatment (P<0.05 or P<0.01),but the improvement was more significant in the combined therapy group(P<0.05 or P<0.01).Conclusion:Budesonide inhalation combined with acanthopanax senticosus injection infused intravenously is an effective and safe therapy in treating patients with neuroasthma.

关 键 词：支气管哮喘 神经性 刺五加注射液 布地奈德 联合治疗 

分 类 号：R562.25[医药卫生—呼吸系统]